Works by Call, Timothy G.

Results: 90
    1
    2
    3

    Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 9, p. 1, doi. 10.1038/s41408-022-00721-6
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Ailawadhi, Sikander;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Sher, Taimur;
    • Hanson, Curtis A.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    4

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    5
    6

    Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00477-5
    By:
    • Wang, Yucai;
    • Sinha, Sutapa;
    • Wellik, Linda E.;
    • Secreto, Charla R.;
    • Rech, Karen L.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Koehler, Amber B.;
    • Van Dyke, Daniel L.;
    • Leis, Jose F.;
    • Slager, Susan L.;
    • Dong, Haidong;
    • Kay, Neil E.;
    • He, Rong;
    • Ding, Wei
    Publication type:
    Article
    7

    Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia.

    Published in:
    2021
    By:
    • Hampel, Paul J.;
    • Parikh, Sameer A.;
    • Call, Timothy G.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Al-Kali, Aref;
    • Rabe, Kari G.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Hanson, Curtis A.;
    • Van Dyke, Daniel L.;
    • Shi, Min;
    • Ding, Wei
    Publication type:
    Letter
    8
    9

    Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0220-x
    By:
    • Clay-Gilmour, Alyssa I.;
    • Rishi, Abdul R.;
    • Goldin, Lynn R.;
    • Greenberg-Worisek, Alexandra J.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Maurer, Matthew J.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Brice Weinberg, J.;
    • Camp, Nicola J.;
    • Cerhan, James R.;
    • Leis, Jose;
    • Norman, Aaron;
    • Murray, David L.;
    • Vincent Rajkumar, S.;
    • Caporaso, Neil E.;
    • Landgren, Ola;
    • McMaster, Mary L.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 10, p. 2383, doi. 10.1080/10428194.2020.1768384
    By:
    • Koehler, Amber B.;
    • Leung, Nelson;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Achenbach, Sara J.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Hayman, Suzanne R.;
    • Hampel, Paul J.;
    • Finnes, Heidi D.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    16

    Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 7, p. 1592, doi. 10.1080/10428194.2020.1737684
    By:
    • Bubik, Rachel J.;
    • Barth, Dylan M.;
    • Hook, Christopher;
    • Wolf, Robert C.;
    • Muth, Jessica M.;
    • Mara, Kristin;
    • Patnaik, Mrinal S.;
    • Pruthi, Rajiv K.;
    • Marshall, Ariela L.;
    • Litzow, Mark R.;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Begna, Kebede H.;
    • Alkhateeb, Hassan;
    • Pardanani, Animesh;
    • Ashrani, Aneel A.;
    • Call, Timothy G.;
    • Rivera, Candido E.;
    • Camoriano, John K.
    Publication type:
    Article
    17

    Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 11, p. 2712, doi. 10.1080/10428194.2019.1602268
    By:
    • Hampel, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Witzig, Thomas E.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    18
    19

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL).

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 7, p. 1630, doi. 10.1080/10428194.2016.1257795
    By:
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.;
    • Noseworthy, Peter A.;
    • Goede, Valentin;
    • Chaffee, Kari G.;
    • Bahlo, Jasmin;
    • Call, Timothy G.;
    • Schwager, Susan M.;
    • Ding, Wei;
    • Eichhorst, Barbara;
    • Fischer, Kirsten;
    • Leis, Jose F.;
    • Chanan-Khan, Asher Alban;
    • Hallek, Michael;
    • Slager, Susan L.;
    • Kay, Neil E.
    Publication type:
    Article
    20

    Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice.

    Published in:
    Leukemia & Lymphoma, 2017, v. 58, n. 6, p. 1376, doi. 10.1080/10428194.2016.1251592
    By:
    • Finnes, Heidi D.;
    • Chaffee, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Bowen, Deborah A.;
    • Conte, Michael;
    • McCullough, Kristen B.;
    • Merten, Julianna A.;
    • Bartoo, Gabriel T.;
    • Smith, Matthew D.;
    • Leis, Jose;
    • Chanan-Khan, Asher;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 11, p. E318, doi. 10.1002/ajh.27060
    By:
    • Kosydar, Samuel R.;
    • Parikh, Sameer A.;
    • Lester, Scott C.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Burlile, Jessica F.;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Call, Timothy G.;
    • Breen, William G.;
    • Hampel, Paul J.
    Publication type:
    Article
    27

    Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 1, p. 90, doi. 10.1002/ajh.26388
    By:
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Johnson, Michael J.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Hayman, Suzanne R.;
    • Wang, Yucai;
    • Hampel, Paul J.;
    • Holets, Matthew A.;
    • Darby, Heather C.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Miao, Congrong;
    • Canniff, Jennifer;
    • Whitaker, Jennifer A.;
    • Levin, Myron J.;
    • Schmid, D. Scott
    Publication type:
    Article
    28

    The prognostic significance of del6q23 in chronic lymphocytic leukemia.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 6, p. E203, doi. 10.1002/ajh.26168
    By:
    • Audil, Hadiyah Y.;
    • Hampel, Paul J.;
    • Van Dyke, Daniel L.;
    • Achenbach, Sara J.;
    • Rabe, Kari G.;
    • Smoley, Stephanie A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Wang, Yucai;
    • Muchtar, Eli;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Parikh, Sameer A.
    Publication type:
    Article
    29

    Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis.

    Published in:
    American Journal of Hematology, 2021, v. 96, n. 5, p. E146, doi. 10.1002/ajh.26119
    By:
    • Goyal, Gaurav;
    • Abeykoon, Jithma P.;
    • Hu, Marie;
    • Young, Jason R.;
    • Shah, Mithun V.;
    • Bennani, N. Nora;
    • Call, Timothy G.;
    • Hook, C. Christopher;
    • Pardanani, Animesh;
    • Inwards, David J.;
    • Vassallo, Robert;
    • Ryu, Jay H.;
    • Tobin, W. Oliver;
    • Koster, Matthew J.;
    • Davidge‐Pitts, Caroline J.;
    • Ravindran, Aishwarya;
    • Rech, Karen L.;
    • Go, Ronald S.
    Publication type:
    Article
    30

    Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B‐cell lymphocytosis beyond the CLL international prognostic index.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 8, p. 906, doi. 10.1002/ajh.25831
    By:
    • Kleinstern, Geffen;
    • O'Brien, Daniel R.;
    • Li, Xing;
    • Tian, Shulan;
    • Kabat, Brian F.;
    • Rabe, Kari G.;
    • Norman, Aaron D.;
    • Yan, Huihuang;
    • Vachon, Celine M.;
    • Boddicker, Nicholas J.;
    • Call, Timothy G.;
    • Parikh, Sameer A.;
    • Bruins, Laura;
    • Bonolo de Campos, Cecilia;
    • Leis, Jose F.;
    • Shanafelt, Tait D.;
    • Ding, Wei;
    • Cerhan, James R.;
    • Kay, Neil E.;
    • Slager, Susan L.
    Publication type:
    Article
    31

    Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. E57, doi. 10.1002/ajh.25690
    By:
    • Hampel, Paul J.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Muchtar, Eli;
    • Kenderian, Saad S.;
    • Wang, Yucai;
    • Leis, Jose F.;
    • Witzig, Thomas E.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Schwager, Susan M.;
    • Rabe, Kari G.;
    • Van Dyke, Daniel L.;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    32

    IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 3, p. 338, doi. 10.1002/ajh.25385
    By:
    • Fang, Hong;
    • Reichard, Kaaren K.;
    • Rabe, Kari G.;
    • Hanson, Curtis A.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Schwager, Susan M.;
    • Leis, Jose F.;
    • Chanan‐Khan, Asher A.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Smoley, Stephanie A.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Van Dyke, Daniel L.;
    • Parikh, Sameer A.
    Publication type:
    Article
    33

    Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 12, p. 1362, doi. 10.1002/ajh.24915
    By:
    • Hampel, Paul J.;
    • Chaffee, Kari G.;
    • King, Rebecca L.;
    • Simonetto, Douglas;
    • Larson, Melissa C.;
    • Achenbach, Sara;
    • Call, Timothy G.;
    • Ding, Wei;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Chanan-Khan, Asher A.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Schwager, Susan M.;
    • Hanson, Curtis A.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Shanafelt, Tait D.;
    • Parikh, Sameer A.
    Publication type:
    Article
    34

    High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 8, p. E164, doi. 10.1002/ajh.24765
    By:
    • Ravindran, Aishwarya;
    • Sankaran, Janani;
    • Jacob, Eapen K.;
    • Kreuter, Justin D.;
    • Hook, C. Christopher;
    • Gertz, Morie A.;
    • Call, Timothy G.;
    • Pruthi, Rajiv K.;
    • Litzow, Mark R.;
    • Wolanskyj, Alexandra P.;
    • Hogan, William J.;
    • Ashrani, Aneel A.;
    • Begna, Kebede H.;
    • Marshall, Ariela L.;
    • Kyle, Robert A.;
    • Kay, Neil E.;
    • Go, Ronald S.
    Publication type:
    Article
    35

    A phase II randomized trial comparing standard and low dose rituximab combined with alemtuzumab as initial treatment of progressive chronic lymphocytic leukemia in older patients: a trial of the ECOG-ACRIN cancer research group (E1908).

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 3, p. 308, doi. 10.1002/ajh.24265
    By:
    • Zent, Clive S.;
    • Victoria Wang, Xin;
    • Ketterling, Rhett P.;
    • Hanson, Curtis A.;
    • Libby, Edward N.;
    • Barrientos, Jacqueline C.;
    • Call, Timothy G.;
    • Chang, Julie E.;
    • Liu, Jane J.;
    • Calvo, Alejandro R.;
    • Lazarus, Hillard M.;
    • Rowe, Jacob M.;
    • Luger, Selina M.;
    • Litzow, Mark R.;
    • Tallman, Martin S.
    Publication type:
    Article
    36
    37

    Chemoimmunotherapy for relapsed/refractory and progressive 17p13-deleted chronic lymphocytic leukemia (CLL) combining pentostatin, alemtuzumab, and low-dose rituximab is effective and tolerable and limits loss of CD20 expression by circulating CLL cells.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 7, p. 757, doi. 10.1002/ajh.23737
    By:
    • Zent, Clive S.;
    • Taylor, Ronald P.;
    • Lindorfer, Margaret A.;
    • Beum, Paul V.;
    • LaPlant, Betsy;
    • Wu, Wenting;
    • Call, Timothy G.;
    • Bowen, Deborah A.;
    • Conte, Michael J.;
    • Frederick, Lori A.;
    • Link, Brian K.;
    • Blackwell, Sue E.;
    • Veeramani, Suresh;
    • Baig, Nisar A.;
    • Viswanatha, David S.;
    • Weiner, George J.;
    • Witzig, Thomas E.
    Publication type:
    Article
    38
    39
    40

    Combined ibrutinib and venetoclax for treatment of patients with ibrutinib‐resistant or double‐refractory chronic lymphocytic leukaemia.

    Published in:
    British Journal of Haematology, 2022, v. 199, n. 2, p. 239, doi. 10.1111/bjh.18357
    By:
    • Hampel, Paul J.;
    • Rabe, Kari G.;
    • Call, Timothy G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Wang, Yucai;
    • Koehler, Amber B.;
    • Parrondo, Ricardo;
    • Schwager, Susan M.;
    • Shi, Min;
    • Braggio, Esteban;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Parikh, Sameer A.
    Publication type:
    Article
    41

    Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 1, p. 143, doi. 10.1007/s00277-020-04094-3
    By:
    • Archibald, William J.;
    • Rabe, Kari G.;
    • Kabat, Brian F.;
    • Herrmann, Joerg;
    • Ding, Wei;
    • Kay, Neil E.;
    • Kenderian, Saad S.;
    • Muchtar, Eli;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Chanan-Khan, Asher A.;
    • Schwager, Susan M.;
    • Koehler, Amber B.;
    • Fonder, Amie L.;
    • Slager, Susan L.;
    • Shanafelt, Tait D.;
    • Call, Timothy G.;
    • Parikh, Sameer A.
    Publication type:
    Article
    42

    Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 2, p. 302, doi. 10.1002/hon.2950
    By:
    • Wang, Hanyin;
    • Tian, Shulan;
    • Zhao, Qing;
    • Blumenschein, Wendy;
    • Yearley, Jennifer H.;
    • Secreto, Charla R.;
    • Sinha, Sutapa;
    • Call, Timothy G.;
    • Wang, Yucai;
    • Parikh, Sameer A.;
    • Kenderian, Saad S.;
    • He, Rong;
    • Leis, Jose F.;
    • Shi, Min;
    • Van Dyke, Daniel L.;
    • Kay, Neil E.;
    • Slager, Susan L.;
    • Braggio, Esteban;
    • Yan, Huihuang;
    • Ding, Wei
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49

    The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 10, p. 3390, doi. 10.1002/cam4.2998
    By:
    • Parikh, Sameer A.;
    • Achenbach, Sara J.;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Ding, Wei;
    • Leis, Jose F.;
    • Kenderian, Saad S.;
    • Chanan‐Khan, Asher A.;
    • Koehler, Amber B.;
    • Schwager, Susan M.;
    • Muchtar, Eli;
    • Fonder, Amie L.;
    • McCullough, Kristen B.;
    • Nedved, Adrienne N.;
    • Smith, Matthew D.;
    • Slager, Susan L.;
    • Kay, Neil E.;
    • Finnes, Heidi D.;
    • Shanafelt, Tait D.
    Publication type:
    Article
    50